IRF2BPL-Related Disorder, Causing Neurodevelopmental Disorder with Regression, Abnormal Movements, Loss of Speech and

Sunita Venkateswaran1,2, Jean Michaud3, Yoko Ito1

  • 1Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Canada.

Insights

This study identifies a novel cause of childhood neurodegeneration, interferon regulatory factor 2 binding protein like (IRF2BPL)-related disorder, characterized by spasticity and ataxia, and provides its first pathological description.

Area of Science:

  • Genetics
  • Neurology
  • Pathology

Background:

  • Childhood neurodegenerative diseases present diagnostic challenges due to genetic heterogeneity and varied symptoms.
  • A case of progressive neurodegeneration with spasticity, dystonia, and ataxia is presented.
  • Postmortem analysis revealed interferon regulatory factor 2 binding protein like (IRF2BPL)-related disorder.

Purpose of the Study:

  • To describe the first detailed pathological findings of IRF2BPL-related disorder.
  • To establish NEDAMSS (neurodevelopmental disorder with regression, abnormal movements, loss of speech and seizures) as a distinct clinical entity.
  • To include IRF2BPL-related disorder in the differential diagnosis of spastic-ataxic neurodegenerative conditions.

Main Methods:

  • Postmortem gross and histological examination.
  • Genetic testing, including exome sequencing reanalysis.
  • Analysis of patient-derived cells to assess molecular abnormalities.

Main Results:

  • Pathological findings were initially suggestive of dentatorubral-pallidoluysian atrophy (DRPLA) with polyglutamine (polyQ) inclusions.
  • Exome sequencing identified a pathogenic de novo IRF2BPL variant (c.562C>T, p.(Arg188Ter)).
  • The identified variant led to decreased brain mRNA levels, protein destabilization, and downstream molecular abnormalities.

Conclusions:

  • This study provides the first detailed pathological description of IRF2BPL-related disorder (NEDAMSS).
  • IRF2BPL-related disorder should be considered in the differential diagnosis of spastic-ataxic neurodegenerative conditions.
  • The role of the polyQ repeat tract in pathological inclusions suggests a novel disease mechanism for polyQ repeats.
Abstract

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
499
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
162
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
239